Rifampin: all 278 studies that test it
Page 2 of 3. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy AdultsCompletedNCT05991401Phase 1
- Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary TuberculosisCompletedNCT05896930Phase 2
- A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy ParticipantsCompletedNCT05826574Phase 1
- HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer StudyCompletedNCT05720767Phase 1
- A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558CompletedNCT05685719Phase 1
- Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy ParticipantsCompletedNCT05665647Phase 1
- Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy ParticipantsCompletedNCT05635110Phase 1
- Drug-drug Interaction Study Beteewn ASK120067 and Rifampicin or ItraconazoleCompletedNCT05631678Phase 1
- HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPICompletedNCT05602597Phase 1
- Drug-drug Interaction Study of XZP-3621 TabletStatus unknownNCT05586568Phase 1
- A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy ParticipantsCompletedNCT05577624Phase 1
- A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Febuxostat on the Pharmacokinetics of Methotrexate in Healthy SubjectsCompletedNCT05575297Phase 1
- Efficacy Of Doxycycline & Versus Rifampin In Treatment Of RhinoscleromaStatus unknownNCT05431673Phase 1
- A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the Drug Levels of Digoxin and Rosuvastatin After Coadministration With CC-92480 in Healthy ParticipantsCompletedNCT05389722Phase 1
- EBA, Safety and Tolerability of Sanfetrinem CilexetilCompletedNCT05388448Phase 2
- Drug-drug Interaction Study of SPH3127CompletedNCT05359055Phase 1/2
- A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PKCompletedNCT05357820Phase 1
- DDI Study of OrelabrutinibCompletedNCT05316857Phase 1
- PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor.CompletedNCT05255276Phase 1
- A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy SubjectsStatus unknownNCT05069870Phase 1
- A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult ParticipantsCompletedNCT05057949Phase 1
- A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of AdavosertibTerminatedNCT04959266Phase 1
- Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated TuberculosisActive, not recruitingNCT04951986Phase 3
- Drug Interaction Study of ALXN2050 With Fluconazole and Rifampin in Healthy Adult ParticipantsCompletedNCT04933682Phase 1
- A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196CompletedNCT04914936Phase 1
- Impact of LTBI Treatment on Glucose Tolerance and Chronic InflammationCompletedNCT04830462Phase 4
- The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028Status unknownNCT04808648Phase 1
- Rifampicin at High Dose for Difficult-to-Treat TuberculosisStatus unknownNCT04768231Phase 2
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and PyrazinamideSuspendedNCT04694586Phase 2
- A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult SubjectsCompletedNCT04577885Phase 1
- A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy ParticipantsCompletedNCT04565574Phase 1
- Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy ParticipantsWithdrawnNCT04558216Phase 1
- Fruquintinib CYP3A Inhibitor and Inducer StudyCompletedNCT04557397Phase 1
- Phenotyping of High Dose RifampicinCompletedNCT04525235Phase 1
- High vs. Standard Dose Rifampicin for Effusive Tuberculous PericarditisCompletedNCT04521803Phase 2
- Surufatinib DDI With a PPI and a CYP3A InducerCompletedNCT04510649Phase 1
- A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on FamitinibCompletedNCT04494659Phase 1
- A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult ParticipantsCompletedNCT04410094Phase 1
- The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid TumorsTerminatedNCT04312282Phase 1
- Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy ParticipantsWithdrawnNCT04301310Phase 1
- Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600CompletedNCT04266509Phase 1
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTBStatus unknownNCT04187469Not applicable
- Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon OlorofimCompletedNCT04171739Phase 1
- A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711CompletedNCT04135833Phase 1
- A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With RifampicinCompletedNCT04118842Phase 1
- A Drug Interaction Study of KW-6356 and Clarithromycin or RifampicinCompletedNCT04070495Phase 1
- A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on FluzoparibCompletedNCT04011124Phase 1
- The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult SubjectsCompletedNCT04006353Phase 4
- Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult ParticipantsCompletedNCT03991312Phase 1
- Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMCompletedNCT03927313Phase 2
- A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy SubjectsCompletedNCT03814200Phase 1
- Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and RifampinCompletedNCT03801746Phase 1
- A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin CapsulesCompletedNCT03758469Phase 1
- Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy SubjectsCompletedNCT03755778Phase 1
- An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy ParticipantsCompletedNCT03712540Phase 1
- Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex DiseaseCompletedNCT03672630Phase 2/3
- A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of ClazosentanCompletedNCT03596294Phase 1
- An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy ParticipantsCompletedNCT03563950Phase 1
- The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIHStatus unknownNCT03384121Phase 1
- A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy SubjectsCompletedNCT03346837Phase 1
- Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy SubjectsCompletedNCT03301181Phase 1
- Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)CompletedNCT03278483Phase 4
- Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy VolunteersCompletedNCT03213145Phase 1
- A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy VolunteersStatus unknownNCT03199690Phase 1
- RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TPCompletedNCT03186482Phase 1
- S. Aureus Decolonization in HPN Patients.TerminatedNCT03173053Not applicable
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in DiabeticsCompletedNCT03012529Phase 4
- To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid TumorsCompletedNCT03002493Phase 1
- Drug-drug Interaction Study Between Orally Administered Rifampicin and VilaprisanCompletedNCT02975440Phase 1
- A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy SubjectsCompletedNCT02959060Phase 1
- Optimizing Treatment to Improve TBM Outcomes in ChildrenCompletedNCT02958709Phase 1/2
- A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy SubjectsCompletedNCT02957448Phase 1
- The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB)CompletedNCT02953847Phase 1
- Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)Status unknownNCT02899169Phase 3
- Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered EsketamineCompletedNCT02846519Phase 1
- Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy SubjectsCompletedNCT02809768Phase 1
- Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy SubjectsCompletedNCT02807116Phase 1
- A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy SubjectsCompletedNCT02770222Phase 1
- A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy AdultsCompletedNCT02729467Phase 1
- A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing PotentialCompletedNCT02706535Phase 1
- Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible StaphylococcusCompletedNCT02701608Phase 3
- A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922CompletedNCT02661893Phase 1
- A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady StateCompletedNCT02608034Phase 1
- EVRIOS : Comparative Evaluation of Low Versus High Doses of RifampicinCompletedNCT02599493Phase 4
- A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary TuberculosisCompletedNCT02581527Phase 3
- Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic FibrosisWithdrawnNCT02547116Phase 4
- Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8CompletedNCT02507167Phase 1
- A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult SubjectsCompletedNCT02500667Phase 1
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal TuberculosisStatus unknownNCT02477852Phase 4
- PK Study of Anti-TB DrugsCompletedNCT02457208Phase 1
- Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of FedovapagonCompletedNCT02440841Phase 1
- Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib PharmacokineticsCompletedNCT02430545Phase 1
- Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsCompletedNCT02411435Phase 1
- Effects of Rifampin on the Pharmacokinetics of AtalurenCompletedNCT02409004Phase 1
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy VolunteersCompletedNCT02393586Phase 1
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy VolunteersSuspendedNCT02387242Phase 1
- The Effects of PXR Activation on Hepatic Fat ContentCompletedNCT02329405Phase 4
- Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of DeflazacortCompletedNCT02286635Phase 1
- COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma PatientsCompletedNCT02253420Phase 1
- PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)CompletedNCT02216331Phase 1